Rosalind Advisors, Inc. Q3 2025 Filing

Filed November 13, 2025

Portfolio Value

$292.6B

Holdings

39

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (39 positions)

#StockSharesValue% PortfolioType
1
DCTHDELCATH SYS INC
3,300,389$33.0B11.28%
2
CYTKCYTOKINETICS INC
400,000$22.0B7.51%
3
FRXFENNEC PHARMACEUTICALS INC
2,076,840$19.4B6.64%
4
VSTMVERASTEM INC
1,929,563$17.0B5.82%
5
RZLTREZOLUTE INC
1,807,202$17.0B5.81%
6
XERSXERIS BIOPHARMA HOLDINGS INC
1,795,766$14.6B5.00%
7
YB4PSAVARA INC
4,000,000$14.3B4.88%
8
MDWDMEDIWOUND LTD
749,054$13.5B4.61%
9
VRDNVIRIDIAN THERAPEUTICS INC
600,000$12.9B4.43%
10
CGONCG ONCOLOGY INC
300,000$12.1B4.13%
11
VRNAVERONA PHARMA PLC
100,000$10.7B3.65%
12
IDYAIDEAYA BIOSCIENCES INC
350,000$9.5B3.26%
13
NSPRINSPIREMD INC
3,905,743$9.4B3.22%
14
EYPTEYEPOINT PHARMACEUTICALS INC
650,000$9.3B3.16%
15
BRD1EURMIND MEDICINE MINDMED INC
750,000$8.8B3.02%
16
HELPCYBIN INC
1,500,000$8.8B3.02%
17
GUTSFRACTYL HEALTH INC
5,000,000$8.0B2.72%
18
ATYRATYR PHARMA INC
1,039,080$7.6B2.59%
19
QUREUNIQURE NV
125,000$7.3B2.49%
20
XFORX4 PHARMACEUTICALS INC
1,544,607$5.3B1.81%
21
OCULOCULAR THERAPEUTIX INC
400,000$4.7B1.60%
22
ATYRATYR PHARMA INC
1,570,200$4.5B1.53%Put
23
TLPHTALPHERA INC
4,385,757$3.9B1.34%
24
PRNPROFOUND MED CORP
692,185$3.4B1.16%
25
MYOMYOMO INC
3,790,788$3.4B1.16%
26
PYPDPOLYPID LTD
918,668$3.1B1.05%
27
QQQINVESCO QQQ TR
250,000$1.6B0.53%Put
28
BFRIBIOFRONTERA INC
1,140,764$1.1B0.38%
29
CATBUSDASTRIA THERAPEUTICS INC
1,542,520$1.1B0.38%
30
LVLNSPDR SERIES TRUST
2,128,300$950.6M0.32%Put
31
TRVITREVI THERAPEUTICS INC
100,000$915.0M0.31%
32
VSTMVERASTEM INC
646,500$898.2M0.31%Call
33
KURAKURA ONCOLOGY INC
100,000$885.0M0.30%
34
SPYSPDR S&P 500 ETF TR
300,000$717.5M0.25%Put
35
RZLTREZOLUTE INC
263,100$546.4M0.19%Call
36
IDYAIDEAYA BIOSCIENCES INC
35,900$236.9M0.08%Call
37
REPLREPLIMUNE GROUP INC
511,400$183.1M0.06%Call
38
AQLTISHARES TR
200,000$20.0M0.01%Put
39
SRRKSCHOLAR ROCK HLDG CORP
100,000$10.0M0.00%Put